Commerce Bank’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.4K Hold
15,000
﹤0.01% 1309
2025
Q4
$10.7K Sell
15,000
-10,000
-40% -$13.6K ﹤0.01% 1240
2025
Q3
$40.5K Sell
25,000
-5,000
-17% -$5.04K ﹤0.01% 1228
2025
Q2
$18.3K Hold
30,000
﹤0.01% 1188
2025
Q1
$17.1K Buy
30,000
+10,000
+50% +$9.87K ﹤0.01% 1171
2024
Q4
$28.6K Buy
+20,000
New +$44.8K ﹤0.01% 1175

Other funds holding TNYA

Commerce Bank's TNYA Position: Q1 2026 in Review

Commerce Bank held its Tenaya Therapeutics (TNYA) position steady in Q1 2026 at 15,000 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1309.

Commerce Bank first reported a position in TNYA in Q4 2024 and has held it in 6 quarters since. The position peaked at $40.5K in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Commerce Bank held 15,000 shares of Tenaya Therapeutics worth $10.4K as of Q1 2026.
  • Commerce Bank left its Tenaya Therapeutics share count unchanged in Q1 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Commerce Bank's portfolio in Q1 2026, its #1309 holding.
  • Commerce Bank first reported a position in Tenaya Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Commerce Bank's Tenaya Therapeutics position peaked at $40.5K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Commerce Bank's 13F filing for Q1 2026, filed 11 May 2026.